Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy
Journal
International journal of cardiology
Journal Volume
202
Pages
962-966
Date Issued
2016-01-01
Author(s)
Chung, Yi-Wei
Yang, Yao-Hsu
Abstract
Whether the spironolactone treatment remains effective for the prevention of atrial fibrillation (AF) in dialysis patients is unclear.
Subjects
Atrial fibrillation; ESRD; Hemodialysis; Spironolactone
SDGs
Publisher
ELSEVIER IRELAND LTD
Type
journal article